Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outset Medical (OM) Inventory (2019 - 2025)

Historic Inventory for Outset Medical (OM) over the last 7 years, with Q4 2025 value amounting to $47.6 million.

  • Outset Medical's Inventory fell 1983.26% to $47.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $47.6 million, marking a year-over-year decrease of 1983.26%. This contributed to the annual value of $47.6 million for FY2025, which is 1983.26% down from last year.
  • Latest data reveals that Outset Medical reported Inventory of $47.6 million as of Q4 2025, which was down 1983.26% from $49.3 million recorded in Q3 2025.
  • Outset Medical's 5-year Inventory high stood at $61.6 million for Q2 2024, and its period low was $24.6 million during Q1 2021.
  • Its 5-year average for Inventory is $48.2 million, with a median of $49.3 million in 2023.
  • In the last 5 years, Outset Medical's Inventory surged by 19040.64% in 2021 and then tumbled by 1983.26% in 2025.
  • Over the past 5 years, Outset Medical's Inventory (Quarter) stood at $39.2 million in 2021, then soared by 31.37% to $51.5 million in 2022, then dropped by 4.39% to $49.2 million in 2023, then increased by 20.67% to $59.4 million in 2024, then fell by 19.83% to $47.6 million in 2025.
  • Its Inventory stands at $47.6 million for Q4 2025, versus $49.3 million for Q3 2025 and $52.2 million for Q2 2025.